These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13262116)

  • 1. [Anticoagulant effect of 2-phenyl-1, 3-indandione].
    POLIAK RIa
    Farmakol Toksikol; 1955; 18(4):30-2. PubMed ID: 13262116
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of nucleophilic and electrophilic substitutes on the anticoagulant action of various 2-phenyl-1, 3-indandione derivatives].
    CAVALLINI G; MILLA E; GRUMMELLI E; RAVENNA F
    Farmaco Sci; 1955; 10(10):710-32. PubMed ID: 13294151
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anticoagulant effect of 2-(4-bromo) phenyl-1, 3-indandione (fluidemin)].
    BONO F; CORTINOVIS R
    Minerva Chir; 1956 Oct; 11(19):949-52. PubMed ID: 13387072
    [No Abstract]   [Full Text] [Related]  

  • 4. THE ANTICOAGULANT ACTION OF 2,2'-ARYLENE-BIS-INDANDIONE-1,3.
    GUMINSKA M; ECKSTEIN M; STACHURSKA B
    Farmaco Sci; 1964 Aug; 19():653-60. PubMed ID: 14180152
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with a new anticoagulant, dipaxin (2-diphenylacetyl-1,3-indandione).
    PASCALE LR; OLWIN JH
    Circulation; 1954 Feb; 9(2):230-7. PubMed ID: 13127184
    [No Abstract]   [Full Text] [Related]  

  • 6. Long term anticoagulant therapy. A six-year study of 43an indandione derivative.
    RAWLS WB; CONNOR CA
    Am J Cardiol; 1959 Oct; 4():470-5. PubMed ID: 14436600
    [No Abstract]   [Full Text] [Related]  

  • 7. Dipaxin: 2-diphenylacetyl-1,3-indandione; clinical evaluation of a new anticoagulant.
    FIELD JB; GOLDFARB MS; WARE AG; GRIFFITH GC
    Circulation; 1955 Apr; 11(4):576-83. PubMed ID: 14364732
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of 2-phenyl-1,3-indandione in the rat after i.v. and oral administration.
    de Vries J; Verboom CN; Groot EJ; Nauta WT; Wattel E
    Eur J Drug Metab Pharmacokinet; 1979; 4(4):225-9. PubMed ID: 535602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [RESEARCH ON THE ANTICOAGULANT ACTION OF AN INDANDIONE DERIVATIVE (ANISINDIONE) WITH PROLONGED ACTION].
    GIBELLI A; DELUTTEROTTI A
    Rass Int Clin Ter; 1964 Jan; 44():1-8. PubMed ID: 14126507
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary clinical investigations on a new indandione type anticoagulant: anisindione].
    BALLERINI G; LA PAGLIA S
    Prog Med (Napoli); 1959 Jan; 15(2):46-8. PubMed ID: 13658270
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trial of a new anticoagulant: 2-(4-bromophenyl)-1,3-indandione].
    BRUNE J; VERNEYRE H; DELAHAYE JP
    Lyon Med; 1962 Mar; 94():565-72. PubMed ID: 13873987
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical studies on the coagulation-inhibiting activity of a new anticoagulant of the indandione series].
    STROBEL E
    Arzneimittelforschung; 1962 Jul; 12():718-20. PubMed ID: 13917816
    [No Abstract]   [Full Text] [Related]  

  • 13. [EXPERIENCE WITH THE USE OF INDANDIONE ANTICOAGULANTS IN MYOCARDIAL INFARCT AND STENOCARDIA].
    ALUSCIN PM; SHAROVA IuA; DEMIDOVA NV
    Klin Med (Mosk); 1964 Jun; 42():83-5. PubMed ID: 14243265
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the phthalides and 1,3-indaniones. XXIX. Preparation and anticoagulation activity of 2-phenyl-1,3-indandiones substituted in the position 5 of the indandione and in the position 4' of the phenyl nucleus].
    Hrnciar P; Hrnciarová M; Kovalcík V
    Cesk Farm; 1968 Mar; 17(3):118-21. PubMed ID: 5666301
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect in man of a new indandione anticoagulant.
    FIELD JB; GOLDFARB MS; WARE AG; GRIFFITH GC
    Proc Soc Exp Biol Med; 1952 Dec; 81(3):678-81. PubMed ID: 13037763
    [No Abstract]   [Full Text] [Related]  

  • 16. [Polarographic properties of 2-aryl derivatives of 1,3-indandione. I. Microcoulometric evaluation of 2-phenyl-1,3-indandione by electroreduction in an alkaline medium].
    DANEK A
    Acta Pol Pharm; 1962; 19():345-9. PubMed ID: 14024881
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-Delivery Silver Nanoparticles: A New Perspective for Phenindione as an Anticoagulant.
    Nikolova S; Milusheva M; Gledacheva V; Feizi-Dehnayebi M; Kaynarova L; Georgieva D; Delchev V; Stefanova I; Tumbarski Y; Mihaylova R; Cherneva E; Stoencheva S; Todorova M
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the anticoagulant phenindione. IV. Its multiphasic effect on the coagulation mechanism.
    ADAMIS D; KIMBALL D; SISE HS
    J Lab Clin Med; 1957 Jan; 49(1):69-83. PubMed ID: 13385578
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the anticoagulant phenindione. III. Its use in ambulatory patients.
    ADAMIS D; DRINAN FW; MOLONEY WC; SISE HS
    Am Heart J; 1957 Feb; 53(2):284-92. PubMed ID: 13394528
    [No Abstract]   [Full Text] [Related]  

  • 20. [CLINICAL OBSERVATIONS ON THE ANTICOAGULANT EFFECT OF FENHYDREN].
    CHOJNOWSKI JR; ADAMSKA-MARCINKOWSKA H
    Pol Tyg Lek; 1963 May; 18():744-7. PubMed ID: 14053670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.